Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Adma Biologics (ADMA) over the last 13 years, with Q3 2025 value amounting to $170000.0.

  • Adma Biologics' Amortizatization of Intangibles fell 3253.97% to $170000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $739000.0, marking a year-over-year decrease of 4832.17%. This contributed to the annual value of $951000.0 for FY2024, which is 6333.85% down from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Amortizatization of Intangibles is $170000.0, which was down 3253.97% from $160000.0 recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Amortizatization of Intangibles registered a high of $981066.0 during Q3 2022, and its lowest value of $160000.0 during Q2 2025.
  • Over the past 5 years, Adma Biologics' median Amortizatization of Intangibles value was $464357.0 (recorded in 2021), while the average stood at $440210.5.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first soared by 10186.92% in 2022, then crashed by 6862.46% in 2024.
  • Quarter analysis of 5 years shows Adma Biologics' Amortizatization of Intangibles stood at $502858.0 in 2021, then fell by 1.79% to $493873.0 in 2022, then soared by 41.33% to $698000.0 in 2023, then plummeted by 68.62% to $219000.0 in 2024, then dropped by 22.37% to $170000.0 in 2025.
  • Its Amortizatization of Intangibles was $170000.0 in Q3 2025, compared to $160000.0 in Q2 2025 and $190000.0 in Q1 2025.